Biallelic Inactivating TUB Variants Cause Retinal Ciliopathy Impairing Biogenesis and the Structure of the Primary Cilium

Int J Mol Sci. 2022 Nov 24;23(23):14656. doi: 10.3390/ijms232314656.

Abstract

Inherited retinal degeneration (IRD) represents a clinically variable and genetically heterogeneous group of disorders characterized by photoreceptor dysfunction. These diseases typically present with progressive severe vision loss and variable onset, ranging from birth to adulthood. Genomic sequencing has allowed to identify novel IRD-related genes, most of which encode proteins contributing to photoreceptor-cilia biogenesis and/or function. Despite these insights, knowledge gaps hamper a molecular diagnosis in one-third of IRD cases. By exome sequencing in a cohort of molecularly unsolved individuals with IRD, we identified a homozygous splice site variant affecting the transcript processing of TUB, encoding the first member of the Tubby family of bipartite transcription factors, in a sporadic case with retinal dystrophy. A truncating homozygous variant in this gene had previously been reported in a single family with three subjects sharing retinal dystrophy and obesity. The clinical assessment of the present patient documented a slightly increased body mass index and no changes in metabolic markers of obesity, but confirmed the occurrence of retinal detachment. In vitro studies using patient-derived fibroblasts showed the accelerated degradation of the encoded protein and aberrant cilium morphology and biogenesis. These findings definitely link impaired TUB function to retinal dystrophy and provide new data on the clinical characterization of this ultra-rare retinal ciliopathy.

Keywords: homozygous splice site variant; inherited retinal degeneration; primary cilium; whole exome sequencing.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cilia / genetics
  • Ciliopathies* / genetics
  • Humans
  • Mutation
  • Obesity
  • Pedigree
  • Proteins / genetics
  • Retina
  • Retinal Dystrophies* / genetics

Substances

  • Proteins

Grants and funding

This work was supported by the Ministry of Health funding 5x1000 Fondazione G.B. Bietti funds—2016 to M.P. and Fondazione Roma; Bando Ricerca Indipendente ISS 2021-2023 to V.C., Istituto Superiore di Sanità; Italian Ministry of Health (CCR-2017-23669081 to M.T.), and Italian Ministry of Research (FOE_2019 to M.T.).